Test Price
2,800 AED✅ Home Collection Available
MAMLD1 Gene Hypospadias Type 2, X-Linked Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
This is the UAE’s definitive next-generation sequencing (NGS) test for MAMLD1‑linked X‑linked hypospadias type 2, delivering 99.9% diagnostic sensitivity through high-depth coverage of the entire coding region. The service includes ISO‑certified temperature-controlled cold-chain home collection by a trained phlebotomist, expedited reporting within 3–4 weeks, and complimentary post-test telephonic clinical guidance from our Consultant Medical Genetics. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731. All procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability and relevant UAE health data protection frameworks.
Test Overview & Methodology
The MAMLD1 gene is a principal determinant of X‑linked hypospadias type 2, a congenital condition affecting penile development in males. Our high-depth NGS assay screens all exons and flanking splice sites of MAMLD1, enabling early and precise molecular diagnosis to guide surgical planning, recurrence risk assessment, and familial genetic counselling. Bioinformatics interpretation follows ACMG standards using AI‑powered variant classification for enhanced accuracy.
| Feature | Our Test (MAMLD1 NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Genetic Coverage | Full gene (all exons, splice sites) | One or two exons only |
| Sensitivity | 99.9% (point mutations & copy number variants) | ~95%, may miss deep intronic changes |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Bioinformatics | AI‑powered variant interpretation (ACMG standards) | Manual curation, slower reanalysis |
| Regulatory Compliance | ISO 9001:2015 & DHA/MOHAP licensed | Variable |
Physician Insight & Safety Protocols
As a Consultant Medical Genetics, I emphasise that this MAMLD1 gene test provides essential molecular clarity for confirming X‑linked hypospadias type 2, enabling precise surgical timing and informed family counselling. The result must always be interpreted alongside a thorough clinical examination and a detailed three-generation pedigree. No single genetic finding replaces the comprehensive judgment of your multidisciplinary care team, and patients should continue all prescribed therapies unless explicitly advised otherwise by their treating physician.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory
Important Safety Information
- This test is contraindicated in individuals with an active bleeding disorder, severe anaemia, or a known allergy to phlebotomy antiseptics.
- Seek immediate medical attention if excessive bleeding, prolonged dizziness, or signs of infection at the puncture site occur after blood collection.
- Written informed consent from a legal guardian is mandatory for minors, in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient Exclusion Criteria
Conditions That May Affect Sample Suitability
- Active bleeding diathesis or coagulopathy that precludes routine venipuncture.
- Known allergy to chlorhexidine or isopropyl alcohol used in standard phlebotomy antisepsis.
- Recent blood transfusion within the past 72 hours may confound genetic analysis; please inform the referring physician.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the MAMLD1 gene test for hypospadias type 2?
This genetic test identifies pathogenic mutations in the MAMLD1 gene, confirming X‑linked hypospadias type 2 and enabling precise surgical timing, recurrence risk assessment, and targeted family screening. Early molecular diagnosis supports informed surgical planning and genetic counselling for at-risk relatives.
2. How is the sample collected and what is the turnaround time?
A trained phlebotomist collects 3–5 mL of whole blood in an EDTA tube or a dried blood spot on an FTA card during a scheduled home visit. Results are delivered within 3 to 4 weeks in a comprehensive clinical report that includes variant classification and clinical recommendations.
3. Is this test covered by health insurance in the UAE?
Yes, most major UAE insurance plans cover this genetic test. You can verify your coverage and initiate direct billing by sending your insurance card details via WhatsApp to +971 54 548 8731. Our billing team will confirm eligibility and any applicable copayment or deductible.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
DNA Labs UAE operates under DHA Facility License Number 1143 and adheres strictly to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient data handling. All genetic information is encrypted, access-controlled, and processed in compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and informed consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our ISO 9001:2015 certification (INT/EGQ/2509DA/3139) further underscores our commitment to quality and security.
Clinical & Logistical Metadata
| Test Name | MAMLD1 Gene Hypospadias Type 2, X-Linked Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (21–28 business days) |
| Sample Type / Matrix | Whole blood (EDTA tube) or dried blood spot (FTA card) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | High-depth Next-Generation Sequencing (NGS) of MAMLD1 coding region and splice sites |
| ICD-10-CM Code | Q54.2 (Hypospadias, unspecified), Q54.8 (Other hypospadias) |
| LOINC Code | 81247-9 (Genetic variant assessment NGS panel) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians